World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
34108
World Ranking
1237
National Ranking
646

Medicine

D-Index
88
Citations
34439
World Ranking
13008
National Ranking
6649

Overview

Alfred J. Saah is a researcher affiliated with MSD (United States) focusing primarily on medical sciences, particularly in the fields of epidemiology, surgery, molecular biology, immunology, and microbiology. Their work encompasses 37 publications in medicine with a heavy emphasis on epidemiological studies.

The scientist's major research themes include cervical cancer and HPV research, hepatitis B virus studies, genital health and disease, molecular biology techniques and applications, immunotherapy and immune responses, animal virus infections studies, and herpesvirus infections and treatments.

Alfred J. Saah has published multiple papers on the effectiveness and immunogenicity of human papillomavirus (HPV) vaccines, HPV-associated diseases, and related public health impacts. Notable recent publications include:

  • Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four Nordic countries, 2020, EClinicalMedicine
  • Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence, 2021, Vaccine
  • Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer, 2023, Vaccine
  • Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review, 2022, Expert Review of Vaccines
  • Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial, 2020, Papillomavirus Research

Their frequent co-authors, contributing to collaborative research efforts, include Alain Luxembourg, Anna R. Giuliano, Christine Velicer, Elmar A. Joura, and Susanne K. Kjær.

Alfred J. Saah's publications are prominently featured in well-known scientific journals such as Vaccine, Clinical Infectious Diseases, EClinicalMedicine, Expert Review of Vaccines, and Papillomavirus Research. The Vaccine journal is the most common publication venue for their work, with five contributions.

Best Publications

  • Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

    Michael Dean;Mary Carrington;Cheryl Winkler;Gavin A. Huttley

  • Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

    John W. Mellors;Alvaro Muñoz;Janis V. Giorgi;Joseph B. Margolick

  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade

  • Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

    Richard A. Kaslow;Mary Carrington;R. Apple;L. Park

  • KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

    Shou-Jiang Gao;Lawrence Kingsley;Ming Li;Wei Zheng

  • The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

    John Phair;Alvaro Muñoz;Roger Detels;Richard Kaslow

  • Dementia in AIDS patients: Incidence and risk factors

    J. C. McArthur;D. R. Hoover;H. Bacellar;E. N. Miller

  • High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

    L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade

  • Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

    Shou Jiang Gao;Lawrence Kingsley;Donald R. Hoover;Thomas J. Spira

  • Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Luisa L. Villa;Kevin A. Ault;Anna R. Giuliano;Ronaldo L.R. Costa

  • Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

    Nubia Muñoz;Ricardo Manalastas;Punee Pitisuttithum;Damrong Tresukosol

  • Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

    Suzanne M. Garland;Susanne K. Kjaer;Nubia Muñoz;Stan L. Block

  • Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation.

    Henderson Dk;Fahey Bj;Willy M;Schmitt Jm

  • Clinical manifestations of AIDS in the ERA of pneumocystis prophylaxis

    Donald R. Hoover;Alfred J. Saah;Helena Bacellar;John Phair

  • Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

    Justin C. McArthur;Daniel R. McClernon;Michael F. Cronin;Tish E. Nance-Sproson

  • End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

    X Castellsague;N Munoz;P Pitisuttithum;Daron G. Ferris

  • Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    Sven-Eric Olsson;Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta

  • A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

    Susanne K. Kjaer;Kristján Sigurdsson;Ole-Erik Iversen;Mauricio Hernandez-Avila

  • Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men

    A. M. Tang;N. M. H. Graham;A. J. Kirby;L. D. Mccall

  • Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease.

    Terry McNearney;Zuzana Hornickova;Richard Markham;Anahid Birdwell

  • HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages

    O. A. Selnes;E. Miller;J. McArthur;B. Gordon

Frequent Co-Authors

Donald R. Hoover
Donald R. Hoover Rutgers, The State University of New Jersey
Roger Detels
Roger Detels University of California, Los Angeles
John P. Phair
John P. Phair Northwestern University
Richard A. Kaslow
Richard A. Kaslow Yale School of Medicine
Charles R. Rinaldo
Charles R. Rinaldo University of Pittsburgh
Neil M.H. Graham
Neil M.H. Graham Regeneron (United States)
Joseph B. Margolick
Joseph B. Margolick Johns Hopkins University
Joan S. Chmiel
Joan S. Chmiel Northwestern University
Lawrence A. Kingsley
Lawrence A. Kingsley University of Pittsburgh
Alvaro Muñoz
Alvaro Muñoz Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students complement their immunology knowledge with nursing degrees to enhance clinical understanding and patient care skills. For those interested in transitioning into nursing without prior experience, programs like online rn programs for non nurses in florida offer flexible online options tailored for career changers.

If you're looking for faster routes into nursing, exploring the easiest accelerated nursing programs to get into can be a strategic move. These programs help students quickly gain the credentials required for advanced practice roles.

For those considering practical nursing, identifying the easiest lpn programs to get into may provide an accessible pathway into healthcare while building foundational clinical skills.

Advanced practice nurses can further specialize by finding which nurse practitioner program is easiest to enter, enabling quicker progression into roles that combine patient care with immunology insights. Together, these pathways offer diverse options for immunology graduates aiming to impact healthcare directly.

Best Scientists Citing Alfred J. Saah

Trending Scientists